Internal Medicine, Gastroenterology · Columbia, MD
NPI
1346213824
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
7120 Minstrel Way, Suite 100
Columbia, MD, 21045
Phone (410) 290-6677
Groups this clinician bills Medicare through
Medicare paid, 2024
$458K
20,773 services
Medicare patients, 2024
424
Average age 72
Drug cost, 2024
$1.4M
941 prescriptions
Company payments, 2025
$12K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rudrajit M Rai was code J3380 (injection, vedolizumab, intravenous, 1 mg), 17,400 times for 11 patients. In total Rudrajit M Rai billed 20,773 services in 32 codes, and Medicare paid $458K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 17,400 | 11 | $16.37 | $285K |
| 99214 Office E&M - Established | Office | 686 | 333 | $96.65 | $66K |
| 99213 Office E&M - Established | Office | 156 | 142 | $61.56 | $9,603 |
| 45380 Lower GI Endoscopy - Other | Facility | 136 | 134 | $136.22 | $19K |
| 43239 Upper GI Endoscopy | Facility | 125 | 118 | $80.78 | $10K |
| 96413 Chemotherapy Administration | Office | 63 | 19 | $100.20 | $6,313 |
| 99203 Office E&M - New | Office | 43 | 43 | $69.88 | $3,005 |
| 99204 Office E&M - New | Office | 33 | 33 | $118.80 | $3,921 |
| 45385 Colonoscopy - Lesion Removal | Facility | 28 | 28 | $209.02 | $5,853 |
| 43450 Digestive/Gastrointestinal | Facility | 28 | 27 | $31.35 | $878 |
| 91110 Standard X-ray | Office | 23 | 22 | $600.58 | $14K |
| 96365 Intravenous Infusion, Hydration | Office | 22 | 11 | $45.27 | $996 |
By year: 2022 $727K for 24,517 services; 2023 $540K for 23,120 services; 2024 $458K for 20,773 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83013 Clinical Chemistry | 15 | 12 | $66.28 | $994 |
| 83014 Clinical Chemistry | 15 | 12 | $7.73 | $116 |
Medicare prescription drug claims, 2024
In 2024, the drug Rudrajit M Rai prescribed most often to Medicare patients was Mesalamine Er (Mesalamine), with 168 prescriptions and refills. In total Rudrajit M Rai wrote 941 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mesalamine Er Mesalamine | 168 | 313 | 51 | $52K |
| Famotidine Generic | 126 | 320 | 51 | $1,875 |
| Pantoprazole Sodium Generic | 123 | 248 | 49 | $1,776 |
| Linzess Linaclotide | 51 | 99 | 17 | $51K |
| Omeprazole Generic | 41 | 87 | 15 | $413 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 35 | 35 | 34 | $596 |
| Sucralfate Generic | 29 | 39 | 15 | $1,863 |
| Mesalamine Generic | 26 | 41 | Under 11 | $14K |
| Stelara Ustekinumab | 23 | 43 | Under 11 | $605K |
| Humira(Cf) Pen Adalimumab | 21 | 23 | Under 11 | $162K |
| Dexlansoprazole Dr Dexlansoprazole | 20 | 42 | Under 11 | $8,023 |
| Methotrexate Methotrexate Sodium | 20 | 33 | Under 11 | $333 |
| Budesonide Ec Budesonide | 19 | 19 | Under 11 | $1,461 |
| Budesonide Dr Budesonide | 16 | 16 | 13 | $2,256 |
| Dicyclomine Hcl Generic | 15 | 17 | Under 11 | $271 |
Brand drugs: 227 claims; generic drugs: 714 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rudrajit M Rai $12K ($12K in general payments such as food, travel and fees) from 20 companies. The largest payer was Gilead Sciences, Inc. with $7,825.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 5 | $7,825 |
| Intercept Pharmaceuticals, Inc. | 3 | $1,811 |
| Abbvie Inc. ABBV | 28 | $525 |
| Janssen Biotech, Inc. JNJ | 8 | $281 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $250 |
| Pfizer Inc. PFE | 15 | $218 |
| Madrigal Pharmaceuticals MDGL | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $143 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $93.76 |
| Genzyme Corporation SNY | 3 | $76.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.